Publications by authors named "S N Thibodeau"

Purpose: Stage III non-small cell lung cancer (NSCLC) is a heterogeneous disease, with a spectrum of anatomic extent, health status, and treatment approaches. Receipt of treatment and its intent should be independent of health system factors where care quality is optimal. We investigated the degree that modifiable health system factors are associated with receipt of treatment and treatment intent in stage III NSCLC in a large, universal health system.

View Article and Find Full Text PDF
Article Synopsis
  • Heart failure with preserved ejection fraction (HFpEF) is influenced by various risk factors that affect organs beyond the heart, and a study used a mouse model to explore the effects of metabolic-hypertensive stress and exercise on heart health.
  • After a period of stress, the study found that stopping the stresses and introducing voluntary exercise led to significant cardiac improvements, especially in female mice who experienced loss of cardiac hypertrophy and remodeling.
  • The research also revealed changes in plasma microRNA levels (miRs), which changed in response to stress; however, while plasma levels normalized after recovery, the heart tissue showed persistent abnormalities, indicating that circulatory markers alone may not provide a complete picture of heart health recovery.
View Article and Find Full Text PDF

Single nucleotide polymorphism (SNP) interactions are the key to improving polygenic risk scores. Previous studies reported several significant SNP-SNP interaction pairs that shared a common SNP to form a cluster, but some identified pairs might be false positives. This study aims to identify factors associated with the cluster effect of false positivity and develop strategies to enhance the accuracy of SNP-SNP interactions.

View Article and Find Full Text PDF

We propose a new mouse (C57Bl6/J) model combining several features of heart failure with preserved ejection fraction encountered in older women, including hypertension from Angiotensin II infusion (AngII), menopause, and advanced age. To mimic menopause, we delayed ovariectomy (Ovx) at 12 months of age. We also studied the effects of AngII infusion for 28 days in younger animals and the impact of losing gonadal steroids earlier in life.

View Article and Find Full Text PDF

After menopause, the incidence of cardiovascular disease rapidly rises in women. The disappearing protection provided by sex steroids is a consequence of the development of many risk factors. Preclinical studies are necessary to understand better the effects of ovarian hormones loss cardiac aging.

View Article and Find Full Text PDF